271 related articles for article (PubMed ID: 15649822)
1. Dimethylfumarate for psoriasis: more than a dietary curiosity.
Mrowietz U; Asadullah K
Trends Mol Med; 2005 Jan; 11(1):43-8. PubMed ID: 15649822
[TBL] [Abstract][Full Text] [Related]
2. Fumaric acid esters.
Rostami Yazdi M; Mrowietz U
Clin Dermatol; 2008; 26(5):522-6. PubMed ID: 18755371
[TBL] [Abstract][Full Text] [Related]
3. Dimethylfumarate is a potent inducer of apoptosis in human T cells.
Treumer F; Zhu K; Gläser R; Mrowietz U
J Invest Dermatol; 2003 Dec; 121(6):1383-8. PubMed ID: 14675187
[TBL] [Abstract][Full Text] [Related]
4. Use of fumaric acid esters in psoriasis.
Roll A; Reich K; Boer A
Indian J Dermatol Venereol Leprol; 2007; 73(2):133-7. PubMed ID: 17456929
[TBL] [Abstract][Full Text] [Related]
5. Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-1, and ICAM-1 expression in human endothelial cells.
Vandermeeren M; Janssens S; Borgers M; Geysen J
Biochem Biophys Res Commun; 1997 May; 234(1):19-23. PubMed ID: 9168952
[TBL] [Abstract][Full Text] [Related]
6. Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
Loewe R; Pillinger M; de Martin R; Mrowietz U; Gröger M; Holnthoner W; Wolff K; Wiegrebe W; Jirovsky D; Petzelbauer P
J Invest Dermatol; 2001 Dec; 117(6):1363-8. PubMed ID: 11886496
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
Landeck L; Asadullah K; Amasuno A; Pau-Charles I; Mrowietz U
Arch Dermatol Res; 2018 Aug; 310(6):475-483. PubMed ID: 29574575
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of dendritic cell differentiation by fumaric acid esters.
Zhu K; Mrowietz U
J Invest Dermatol; 2001 Feb; 116(2):203-8. PubMed ID: 11179994
[TBL] [Abstract][Full Text] [Related]
9. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
[TBL] [Abstract][Full Text] [Related]
10. Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein beta in activated human T cells.
Gerdes S; Shakery K; Mrowietz U
Br J Dermatol; 2007 May; 156(5):838-42. PubMed ID: 17381463
[TBL] [Abstract][Full Text] [Related]
11. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis.
Brück J; Dringen R; Amasuno A; Pau-Charles I; Ghoreschi K
Exp Dermatol; 2018 Jun; 27(6):611-624. PubMed ID: 29603404
[TBL] [Abstract][Full Text] [Related]
12. Effects of monomethylfumarate on dendritic cell differentiation.
Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
[TBL] [Abstract][Full Text] [Related]
13. [Immunomodulation with fumaric acid. Systemic therapy in psoriasis].
Sebók B; Schneider I
Orv Hetil; 2000 Jan; 141(3):129-32. PubMed ID: 10693335
[TBL] [Abstract][Full Text] [Related]
14. Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.
Gesser B; Johansen C; Rasmussen MK; Funding AT; Otkjaer K; Kjellerup RB; Kragballe K; Iversen L
J Invest Dermatol; 2007 Sep; 127(9):2129-37. PubMed ID: 17495961
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria with fumaric acid ester treatment for psoriasis.
Ogilvie S; Lewis Jones S; Dawe R; Foerster J
Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009
[TBL] [Abstract][Full Text] [Related]
16. Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1.
Lehmann JC; Listopad JJ; Rentzsch CU; Igney FH; von Bonin A; Hennekes HH; Asadullah K; Docke WD
J Invest Dermatol; 2007 Apr; 127(4):835-45. PubMed ID: 17235328
[TBL] [Abstract][Full Text] [Related]
17. In vitro pharmacokinetics of anti-psoriatic fumaric acid esters.
Litjens NH; van Strijen E; van Gulpen C; Mattie H; van Dissel JT; Thio HB; Nibbering PH
BMC Pharmacol; 2004 Oct; 4():22. PubMed ID: 15479475
[TBL] [Abstract][Full Text] [Related]
18. Nail psoriasis improvement in a patient treated with fumaric acid esters.
Vlachou C; Berth-Jones J
J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
[TBL] [Abstract][Full Text] [Related]
19. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
Balasubramaniam P; Stevenson O; Berth-Jones J
Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
[TBL] [Abstract][Full Text] [Related]
20. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
Bovenschen HJ; Langewouters AM; van de Kerkhof PC
Am J Clin Dermatol; 2010; 11(5):343-50. PubMed ID: 20553063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
